| Literature DB >> 34925273 |
Chia-Ru Chung1, Zhuo Wang2, Jing-Mei Weng1, Hsin-Yao Wang3,4, Li-Ching Wu5, Yi-Ju Tseng3,6, Chun-Hsien Chen3,7, Jang-Jih Lu3,8,9, Jorng-Tzong Horng1,10, Tzong-Yi Lee2.
Abstract
As antibiotics resistance on superbugs has risen, more and more studies have focused on developing rapid antibiotics susceptibility tests (AST). Meanwhile, identification of multiple antibiotics resistance on Staphylococcus aureus provides instant information which can assist clinicians in administrating the appropriate prescriptions. In recent years, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a powerful tool in clinical microbiology laboratories for the rapid identification of bacterial species. Yet, lack of study devoted on providing efficient methods to deal with the MS shifting problem, not to mention to providing tools incorporating the MALDI-TOF MS for the clinical use which deliver the instant administration of antibiotics to the clinicians. In this study, we developed a web tool, MDRSA, for the rapid identification of oxacillin-, clindamycin-, and erythromycin-resistant Staphylococcus aureus. Specifically, the kernel density estimation (KDE) was adopted to deal with the peak shifting problem, which is critical to analyze mass spectra data, and machine learning methods, including decision trees, random forests, and support vector machines, which were used to construct the classifiers to identify the antibiotic resistance. The areas under the receiver operating the characteristic curve attained 0.8 on the internal (10-fold cross validation) and external (independent testing) validation. The promising results can provide more confidence to apply these prediction models in the real world. Briefly, this study provides a web-based tool to provide rapid predictions for the resistance of antibiotics on Staphylococcus aureus based on the MALDI-TOF MS data. The web tool is available at: http://fdblab.csie.ncu.edu.tw/mdrsa/.Entities:
Keywords: AST (antibiotic susceptibility testing); MALDI-TOF MS; antibiotics susceptibility test; machine learning; multidrug resistance
Year: 2021 PMID: 34925273 PMCID: PMC8678511 DOI: 10.3389/fmicb.2021.766206
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Number of data in training and independent testing sets.
| Training set | Independent testing set | |||
| Antibiotics | Resistant (%) | Susceptible (%) | Resistant (%) | Susceptible (%) |
| Oxacillin | 10,735 (53.11) | 9,477 (46.89) | 2,399 (47.93) | 2,606 (52.07) |
| Clindamycin | 9,297 (46.00) | 10,915 (54.00) | 1,880 (37.56) | 3,125 (62.44) |
| Erythromycin | 11,304 (55.93) | 8,908 (44.07) | 2,584 (51.63) | 2,421 (48.37) |
FIGURE 1Flow chart of constructing a reference spectrum template.
FIGURE 2Distribution of number of peaks retrieved from each spectrum in (A) oxacillin-resistant, (B) oxacillin-susceptible, (C) clindamycin-resistant, (D) clindamycin-susceptible, (E) erythromycin-resistant, and (F) erythromycin-susceptible Staphylococcus aureus.
FIGURE 3Distribution of number of spectra that were derived from oxacillin- (upper), clindamycin- (middle), and erythromycin-resistant/susceptible (bottom) Staphylococcus aureus isolates at each M/Z.
FIGURE 4Distribution of number of spectra that were derived from oxacillin- (upper), clindamycin- (middle), and erythromycin-resistant/susceptible (bottom) Staphylococcus aureus isolates at M/Z = 2,000–3,000.
Results of with or without kernel density estimation (KDE) preprocessing on independent testing set.
| Antibiotics | Metrics | Without KDE preprocessing | Using KDE preprocessing |
| OX | SN | 0.7962 | 0.7524 |
| VME | 0.2038 | 0.2476 | |
| SP | 0.7149 | 0.8711 | |
| ME | 0.2851 | 0.1289 | |
| ACC | 0.7538 | 0.8142 | |
| AUC | 0.7555 | 0.8117 | |
| CC | SN | 0.7282 | 0.6489 |
| VME | 0.2718 | 0.3511 | |
| SP | 0.7859 | 0.9261 | |
| ME | 0.2141 | 0.0739 | |
| ACC | 0.7642 | 0.8220 | |
| AUC | 0.7571 | 0.7875 | |
| E | SN | 0.7693 | 0.6908 |
| VME | 0.2307 | 0.3092 | |
| SP | 0.5857 | 0.8055 | |
| ME | 0.4143 | 0.1945 | |
| ACC | 0.6805 | 0.7463 | |
| AUC | 0.6775 | 0.7481 |
OX, oxacillin; CC, clindamycin; E, erythromycin; SN, sensitivity; VME, very major error; SP, specificity; ME, major error; ACC, accuracy; AUC, area under the receiver operating characteristic curve.
Performance of features selection on independent test set.
| Model | |||
| Oxacillin | Clindamycin | Erythromycin | |
| Number of features | 36 | 38 | 37 |
| Sensitivity | 0.7545 | 0.6809 | 0.6811 |
| Very major error | 0.2455 | 0.3191 | 0.3189 |
| Specificity | 0.8526 | 0.9104 | 0.8174 |
| Major error | 0.1474 | 0.0896 | 0.1826 |
| Accuracy | 0.8706 | 0.8242 | 0.7471 |
| AUC | 0.8036 | 0.7956 | 0.7493 |
AUC, Area under the receiver operating characteristic curve.
FIGURE 5The top 9 selected peaks distributions of the M/Z values without peaks alignment for oxacillin-resistant (red)/susceptible (blue) data.